Knowledge Content
After eating, the intestines secrete GLP-1, which first acts on the pancreas: when blood sugar rises, it promotes insulin secretion and inhibits the release of glucagon, steadily lowering blood sugar and preventing rollercoaster-like fluctuations; at the same time, it slows gastric emptying, allowing food to stay in the stomach longer, naturally increasing satiety and reducing the intake of high-calorie foods.https://www.fiercerawsource.com/peptides/premium-high-purity-peptides-glp-1.html
In terms of weight loss, it can directly act on the brain's appetite center, reducing hunger, and can also regulate fat metabolism, reducing fat accumulation, especially targeting abdominal visceral fat, making it easier to achieve "fat loss without muscle loss" than simple dieting.
Recent studies have found that GLP-1 also possesses cardiovascular protective effects, improving vascular endothelial function, lowering blood pressure and blood lipids, and reducing the risk of cardiovascular disease in patients with type 2 diabetes. It can also alleviate hepatic steatosis and has an auxiliary effect in improving non-alcoholic fatty liver disease.
More importantly, it has a comprehensive regulatory effect on metabolic syndrome-simultaneously improving multiple problems such as hyperglycemia, obesity, and hyperlipidemia. Furthermore, it relies on a "glycemia-dependent" mechanism, resulting in an extremely low risk of hypoglycemia. This allows the body to achieve healthy remodeling within its natural metabolic rhythm, making it one of the core research directions in the field of metabolism today.
